Anti-tumoural effects of cannabinoid combinations
US8632825B2 · kind B2 · utility
28Cited by
2References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 4, 2009 |
| Grant date | Jan 21, 2014 |
| Priority date | — |
| Expiry date | Jun 4, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumor, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.